Page last updated: 2024-08-18

pyrroles and Cachexia

pyrroles has been researched along with Cachexia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bora, V; Goyal, RK; Johar, K; Patel, BM; Patel, D1
Bani, MR; Bassi, A; Bisighini, C; Damia, G; Fiordaliso, F; Ghilardi, C; Giavazzi, R; Moschetta, M; Piccirillo, R; Pretto, F; Rovida, A; Scarlato, V; Talamini, L1
Giavazzi, R; Piccirillo, R1
Baracos, VE; Bathe, OF; Cervo, L; Giavazzi, R; Lecker, SH; Martinelli, GB; Olivari, D; Ottoboni, L; Piccirillo, R; Re Cecconi, AD; Resovi, A; Stretch, C; Talamini, L1
Audrain, O; Boucher, E; Leroux, C; Picot, D; Raoul, JL; Zoheir, Y1

Other Studies

5 other study(ies) available for pyrroles and Cachexia

ArticleYear
Systemic study of selected histone deacetylase inhibitors in cardiac complications associated with cancer cachexia.
    Canadian journal of physiology and pharmacology, 2022, Volume: 100, Issue:3

    Topics: Animals; Benzamides; Butyric Acid; Cachexia; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Female; Heart Diseases; Histone Deacetylase Inhibitors; Hydroxamic Acids; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Pyridines; Pyrroles

2022
Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle.
    Oncotarget, 2015, Feb-20, Volume: 6, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Cachexia; Carcinoma, Renal Cell; Cell Line, Tumor; Female; Humans; Indoles; Kidney Neoplasms; Male; Mice, Inbred C57BL; Mice, Nude; Muscle Proteins; Muscle, Skeletal; Protein Kinase Inhibitors; Pyrroles; Signal Transduction; STAT3 Transcription Factor; Sunitinib; Time Factors; Tripartite Motif Proteins; Tumor Burden; Ubiquitin-Protein Ligases; Weight Loss; X-Ray Microtomography; Xenograft Model Antitumor Assays

2015
Inactivating STAT3: bad for tumor, good for muscle.
    Cell cycle (Georgetown, Tex.), 2015, Volume: 14, Issue:7

    Topics: Angiogenesis Inhibitors; Animals; Cachexia; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Male; Muscle Proteins; Muscle, Skeletal; Protein Kinase Inhibitors; Pyrroles; STAT3 Transcription Factor; Ubiquitin-Protein Ligases

2015
Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.
    Oncogene, 2016, 12-01, Volume: 35, Issue:48

    Topics: Animals; Benzylamines; Biomarkers; Cachexia; Chemokine CXCL12; Cyclams; Cytokines; Disease Models, Animal; Female; Gene Expression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Indoles; Male; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Atrophy; Neoplasms; Pyrroles; Rats; Receptors, CXCR4; Signal Transduction; Sunitinib

2016
Changes in resting energy expenditure (REE) as a function of tumor response to sunitinib in a cachexic patient with a metastatic endocrine tumor of the pancreas.
    Acta oncologica (Stockholm, Sweden), 2010, Volume: 49, Issue:8

    Topics: Antineoplastic Agents; Cachexia; Calorimetry, Indirect; Eating; Energy Metabolism; Hepatectomy; Humans; Indoles; Liver Neoplasms; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Pyrroles; Rest; Splenectomy; Sunitinib; Treatment Outcome; Weight Loss

2010